STRATEGIES TO COUNTERACT RESISTANCE MECHANISMS IN CAR+ T-CELL-BASED IMMUNOTHERAPY FOR TRIPLE-NEGATIVE BREAST CANCER
$1,023,084FY2016Department of the ArmyDOD
The General Hospital Corporation
Investigators
View source on USAspending →STRATEGIES TO COUNTERACT RESISTANCE MECHANISMS IN CAR+ T-CELL-BASED IMMUNOTHERAPY FOR TRIPLE-NEGATIVE BREAST CANCER · GrantIndex